Syndax Pharmaceuticals, Inc. Employee Count
The employee counts Syndax Pharmaceuticals, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 298; Filing 2026-02-26.
- 2024-12-31: Employees (as filed) 270; Filing 2025-03-03.
- 2023-12-31: Employees (as filed) 184; Filing 2024-02-27.
- 2022-12-31: Employees (as filed) 107; Filing 2023-02-28.
- Available history
- 2022-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 298 full-time | 2026-02-26 | |
| 2024-12-31 | 270 full-time | 2025-03-03 | |
| 2023-12-31 | 184 full-time | 2024-02-27 | |
| 2022-12-31 | 107 full-time | 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |